The California Department of Health has issued an All Facilities Letter advising healthcare facilities, including nursing homes, to take action regarding a voluntary recall of all unexpired Ameridose products. This recall is a result of the FDA's ongoing inspection of the Ameridose facility and their recommendation for improvements in sterility testing processes. Affected facilities should immediately examine their inventory, quarantine recalled products, and complete a form detailing the status of these products to be returned to Ameridose. The recall letter and form can be found on the Ameridose website. Customers with questions can contact Ameridose directly, and any adverse reactions or quality problems should be reported to the FDA's MedWatch Adverse Event Reporting program.

Summaries are generataed using AI. Check important information.